Alfinor

Betahistine Dihydrochloride, the active ingredient in Alfinor, is a histamine H1 receptor agonist and H3 antagonist presented as a 24 mg oral tablet for systemic use. It is used to manage symptoms associated with Ménière's disease, vertigo, and other vestibular disorders in adults.

GNH USA supplies Alfinor as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide.

Alfinor is indicated for the treatment of vestibular disorders, primarily targeting symptoms associated with Ménière's disease and vertigo. It helps to alleviate symptoms such as:

- Ménière's disease: Reduces the frequency and severity of vertigo attacks, tinnitus, and hearing loss. - Vertigo: Improves balance and reduces episodes of dizziness. - Balance disorders: Enhances stability and coordination in individuals with vestibular dysfunction.

Alfinor may cause several side effects, ranging from mild to severe. Common side effects include:

Common Side Effects: - Nausea: Mild stomach discomfort or vomiting. - Headache: Mild to moderate headache. - Dizziness: Temporary feelings of lightheadedness. - Digestive issues: Mild gastrointestinal disturbances.

Serious or Rare Side Effects: - Allergic reactions: Rare but possible, including skin rash or itching. - Severe dizziness: Persistent or severe vertigo. - Gastrointestinal bleeding: Rare but serious, requiring immediate medical attention.

Alfinor should be used with caution in certain populations and conditions. Key precautions include:

- Pregnancy: Consult a healthcare provider before use during pregnancy. - Breastfeeding: Use with caution and under medical supervision. - Asthma: Monitor closely for respiratory effects. - Peptic ulcers: Use with caution due to potential gastrointestinal effects. - Allergies: Avoid if allergic to betahistine or any excipients. - Store below 25°C: Keep in the original pack, protect from moisture.

Alfinor may interact with other medications, potentially affecting its efficacy or safety. Major and moderate interactions include:

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): Avoid concurrent use due to potential severe interactions. - Antihistamines: May reduce the effectiveness of Alfinor.

Moderate Interactions (Monitor Closely): - Anticholinergics: May exacerbate side effects such as dry mouth and constipation. - Sedatives: May enhance drowsiness and dizziness. - Antidepressants: Monitor for increased side effects.